[Scrutiny of pulmonary metastasectomy].
Scrutiny of pulmonary metastasectomy Patients fulfilling the criteria for pulmonary metastasectomy are heavily selected, belong to the benign end of the malignancy spectrum and have automatically a favourable survival. The current five-year survival of 40% is probably due to selection mechanisms, and the possible contribution of surgery is not proven. Further studies are necessary. Sweden seems to have uniquely good conditions to make the necessary investigations.